The Study
1093-OR: Metabolite-Driven Reversal of Adipocyte Insulin Resistance Identified by Reliance, a Novel Live Lipolysis Screening Platform
This study tested chemicals on fat cells in a dish to see if they change how the cells respond to insulin. It doesn't show if these chemicals help real people with diabetes—it just shows what might happen in a test tube.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
Scientists made a new tool to watch how insulin stops fat cells from releasing fat, and tested 182 natural chemicals to see which ones help insulin work better.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 544 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — if these chemicals work in people, they could help treat insulin resistance and type 2 diabetes by making fat cells respond better to insulin.
- 229 chemicals worked as well as a known diabetes drug (rosiglitazone); EPA and DHA (omega-3s) and dopamine were especially good at helping insulin work.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Diabetes
Year
2026
Authors
Benjamin Diel, E. Lorza-Gil, Andreas L. Birkenfeld, R. J. von Schwartzenberg, G. Sancar
Related Content
Claims (6)
The RELIANCE platform measures how effectively insulin inhibits fat breakdown in fat cells and identifies compounds that restore this function in cells resistant to insulin.
In fat cells from humans and mice, omega-3 fatty acids EPA and DHA increase the ability of insulin to reduce the breakdown of stored fats.
In fat cells, the compounds kaempferol, curcumin, naringenin, 4-methylcatechol, and dopamine decrease the breakdown of fat by altering the phosphorylation state of hormone-sensitive lipase without involving insulin signaling pathways.
In fat cells that are resistant to insulin, rosiglitazone restores the ability of insulin to stop the breakdown of fat.
Twenty-nine metabolites identified by the RELIANCE platform suppress fat breakdown in fat cells under insulin control as effectively as the drug rosiglitazone.
When cells become resistant to insulin, fat breakdown decreases, leading to less fatty acid release into the blood and more fat accumulation in the liver.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.